StonvexLoading…
StonvexStonvexStonvexWhat you need to know right now
This is an algorithmic assessment of current technical conditions, not investment advice. Past performance does not guarantee future results.
Real-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $3.08 | $3.20 | +3.90% | 9.9M |
| 05-12 | $3.22 | $3.28 | +1.86% | 7.6M |
| 05-13 | $3.26 | $3.55 | +8.90% | 13.7M |
| 05-14 | $3.55 | $3.49 | -1.69% | 11.5M |
| 05-15 | $3.44 | $3.47 | +0.87% | 10.7M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $749.19M | $1.92B | $1.44B | $939.95M |
Operating Income | $27.33M | $-85.53M | $-36.21M | $-11.83M |
Net Income | $27.33M | $-85.55M | $-24.38M | $-10.58M |
EPS (Diluted) | $0.05 | $-0.17 | $-0.07 | $-0.02 |
Total Assets | $697.73M | $541.01M | $559.66M | $574.99M |
Total Liabilities | $358.30M | $232.31M | $218.73M | $230.81M |
Cash & Equivalents | $173.26M | $78.30M | $190.06M | $188.65M |
Free Cash Flow OCF − CapEx | $107.04M | $-68.98M | $-228.00K | $-11.64M |
Shares Outstanding | 532.50M | 511.97M | 510.19M | 508.89M |
No sell-side coverage available for CLOV.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Fundamentals not available for CLOV.
No fundamental metrics available yet for this ticker — common for ETFs, foreign issuers without US listing depth, very recent IPOs, or thinly-traded OTC names. The Financials tab pulls from SEC EDGAR directly and may still have data.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.